UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3843-3850

1998

Volltextzugriff (PDF)

Preoperative Chemoradiation for Patients With Pancreatic Cancer: Toxicity of Endobiliary Stents

Journal of clinical oncology, 2000-02, Vol.18 (4), p.860-867

2000

Volltextzugriff (PDF)

Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4762-4719

2004

Volltextzugriff (PDF)

Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer

Journal of clinical oncology, 2006-03, Vol.24 (7), p.1145-1151

2006

Volltextzugriff (PDF)

A phase II study of irinotecan and cisplatin for metastatic or unresectable high grade neuroendocrine carcinoma

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.15550-15550

2008

Volltextzugriff (PDF)

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Journal of clinical oncology, 2004-07, Vol.22 (13), p.2610-2616

2004

Volltextzugriff (PDF)

A double-blind, randomized, placebo-controlled, phase II study of maintenance enzastaurin with 5-FU/leucovorin plus bevacizumab following first-line therapy for metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3527-3527

2011

Volltextzugriff (PDF)

A double-blind, randomized placebo-controlled, phase II study of maintenance enzastaurin (ENZ) with 5-FU/leucovorin (LV) plus bevacizumab (BV) following first-line therapy for metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.501-501

2011

Volltextzugriff (PDF)

Comparison of ampullary adenocarcinomas and duodenal adenocarcinomas with regard to clinical outcomes and responsiveness to fluoropyrimidine-based chemotherapy

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.204-204

2011

Volltextzugriff (PDF)

Neoadjuvant therapy for adenocarcinomas of the duodenum and ampulla of Vater

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.279-279

2011

Volltextzugriff (PDF)

Role of anticoagulation (AC) in patients with advanced pancreatic cancer (APC) with splanchnic venous thrombosis (SVT)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14622-e14622

2011

Volltextzugriff (PDF)

Osteoclastic giant cell tumor of the pancreas: A distinct clinical and pathologic entity

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14648-e14648

2010

Volltextzugriff (PDF)

Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: A retrospective analysis

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.271-271

2011

Volltextzugriff (PDF)

Relative value of serum cytokines and clinical factors in predicting weight loss in advanced pancreatic cancer (PC)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.208-208

2011

Volltextzugriff (PDF)

Comprehensive analysis of potential predictive biomarkers for insulin-like growth factor type-1 receptor (IGF-1R) targeted therapy in pancreatic cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4052-4052

2011

Volltextzugriff (PDF)

Use of gene expression analysis of periampullary carcinomas to identify biliary-like and intestinal-like subgroups of ampullary and duodenal carcinomas

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.161-161

2011

Volltextzugriff (PDF)

Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2537-2544

2002

Volltextzugriff (PDF)

Use of DPC-4 immunostaining of diagnostic cytology specimens to predict the pattern of tumor progression in locally advanced pancreatic cancer patients (LAPC)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.209-209

2011

Volltextzugriff (PDF)

Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3553-3553

2011

Volltextzugriff (PDF)

Impact of lymph node evaluation on survival for small bowel adenocaricnoma: Analysis of the Surveillance, Epidemiology and End Results (SEER) database

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4596-4596

2009

Volltextzugriff (PDF)

Randomized phase II study of gemcitabine (G) plus anti-IGF-1R antibody MK-0646, G plus erlotinib (E) plus MK-0646 and G plus E for advanced pancreatic cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4026-4026

2011

Volltextzugriff (PDF)

Study of genotypic variations and protein expression of the xCT subunit of cystine/glutamate transporter in pancreatic cancer

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.210-210

2011

Volltextzugriff (PDF)

Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.482-482

2011

Volltextzugriff (PDF)

Phase IB study of the Src inhibitor dasatinib with FOLFOX and cetuximab in metastatic colorectal cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3536-3536

2010

Volltextzugriff (PDF)

Phase I/II study of MK-0646, the humanized monoclonal IGF-1R antibody in combination with gemcitabine or gemcitabine plus erlotinib (E) for advanced pancreatic cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4039-4039

2010

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(227)

Publikationsform

Artikel
(231)

Sprache

Englisch
(231)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(64)
Life Sciences & Biomedicine
(64)
Oncology
(64)
Science & Technology
(64)
Female
(57)
Middle Aged
(44)
Adult
(41)
Aged
(37)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Male
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Tumors
(22)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(20)
Adolescent
(16)
Breast Neoplasms - Drug Therapy
(16)
Treatment Outcome
(15)
Combined Modality Therapy
(14)
Aged, 80 And Over
(10)
Chemotherapy, Adjuvant
(10)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

Preoperative Chemoradiation for Patients With Pancreatic Cancer: Toxicity of Endobiliary Stents

Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas

Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer

A phase II study of irinotecan and cisplatin for metastatic or unresectable high grade neuroendocrine carcinoma

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

A double-blind, randomized, placebo-controlled, phase II study of maintenance enzastaurin with 5-FU/leucovorin plus bevacizumab following first-line therapy for metastatic colorectal cancer (mCRC)

A double-blind, randomized placebo-controlled, phase II study of maintenance enzastaurin (ENZ) with 5-FU/leucovorin (LV) plus bevacizumab (BV) following first-line therapy for metastatic colorectal cancer (mCRC)

Comparison of ampullary adenocarcinomas and duodenal adenocarcinomas with regard to clinical outcomes and responsiveness to fluoropyrimidine-based chemotherapy

Neoadjuvant therapy for adenocarcinomas of the duodenum and ampulla of Vater

Role of anticoagulation (AC) in patients with advanced pancreatic cancer (APC) with splanchnic venous thrombosis (SVT)

Osteoclastic giant cell tumor of the pancreas: A distinct clinical and pathologic entity

Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: A retrospective analysis

Relative value of serum cytokines and clinical factors in predicting weight loss in advanced pancreatic cancer (PC)

Comprehensive analysis of potential predictive biomarkers for insulin-like growth factor type-1 receptor (IGF-1R) targeted therapy in pancreatic cancer

Use of gene expression analysis of periampullary carcinomas to identify biliary-like and intestinal-like subgroups of ampullary and duodenal carcinomas

Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome

Use of DPC-4 immunostaining of diagnostic cytology specimens to predict the pattern of tumor progression in locally advanced pancreatic cancer patients (LAPC)

Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer

Impact of lymph node evaluation on survival for small bowel adenocaricnoma: Analysis of the Surveillance, Epidemiology and End Results (SEER) database

Randomized phase II study of gemcitabine (G) plus anti-IGF-1R antibody MK-0646, G plus erlotinib (E) plus MK-0646 and G plus E for advanced pancreatic cancer

Study of genotypic variations and protein expression of the xCT subunit of cystine/glutamate transporter in pancreatic cancer

Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective

Phase IB study of the Src inhibitor dasatinib with FOLFOX and cetuximab in metastatic colorectal cancer

Phase I/II study of MK-0646, the humanized monoclonal IGF-1R antibody in combination with gemcitabine or gemcitabine plus erlotinib (E) for advanced pancreatic cancer

Aktive Filter

Suchergebnisse filtern